VOLIBO M 0.3

Volibo M 0.3 Tablet is classified as an anti-diabetic medication, specifically designed for the management of type 2 diabetes mellitus in adult patients. This medication works by combining different therapeutic agents that assist in regulating blood sugar levels effectively. For optimal results, it is recommended to take Volibo M 0.3 Tablet alongside food and at the same time each day to establish a consistent routine. The prescribing physician will determine the appropriate dosage, which may need to be adjusted based on your individual response and ongoing blood sugar readings. It is important to continue using this medication as prescribed, even if your blood sugar appears to be stable or you feel fine, as discontinuing without medical advice could lead to increased blood sugar levels and elevate the risk of severe complications such as kidney damage, vision loss, nerve issues, and limb loss. In addition to medication, a comprehensive treatment plan should include guidelines regarding diet, exercise, and weight management as directed by your healthcare provider. Lifestyle choices significantly impact diabetes management. Potential side effects include nausea, altered taste perception, decreased appetite, gas, abdominal discomfort, diarrhea, and skin rashes. These effects are often temporary and may resolve on their own; however, it is advisable to seek guidance from your healthcare provider if they persist or cause concern. Volibo M 0.3 Tablet is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe renal or liver impairment. Prior to initiating treatment, it is essential to inform your physician about any history of heart disease, as this may affect the suitability of the medication. Regular monitoring of blood sugar levels is essential, and blood tests may be required to evaluate blood cell counts and liver function during your treatment.